APA (7th ed.) Citation

L, K., & A, H. (2026). Reassuring long-term data on efficacy and safety of pegvisomant monotherapy in a large series of patients with acromegaly. Pituitary, 29(4), . https://doi.org/10.1007/s11102-026-01708-3

Chicago Style (17th ed.) Citation

L, Kasuki, and Heck A. "Reassuring Long-term Data on Efficacy and Safety of Pegvisomant Monotherapy in a Large Series of Patients with Acromegaly." Pituitary 29, no. 4 (2026). https://doi.org/10.1007/s11102-026-01708-3.

MLA (9th ed.) Citation

L, Kasuki, and Heck A. "Reassuring Long-term Data on Efficacy and Safety of Pegvisomant Monotherapy in a Large Series of Patients with Acromegaly." Pituitary, vol. 29, no. 4, 2026, https://doi.org/10.1007/s11102-026-01708-3.